公司资料
NKGen Biotech, Inc. 股价、新闻与催化剂
- 股票代码:
- NKGN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.01 USD (0.00%)
收盘价
最后更新: 2026年8月17日
—
市值
股价为何变动
Current closing-price context is not available for NKGN.
公司概览
业务概览
NKGen Biotech is a cell-therapy company focused on natural killer cell approaches for cancer and immune-related disease. Its story is centered on using engineered immune cells to attack tumors in a different way from CAR-T.
所在地与行业分类
NKGen Biotech is headquartered in the United States and listed on NASDAQ. It sits in cell therapy and oncology biotechnology.
商业模式特征
The company depends on translational validation, manufacturing feasibility, and capital support while developing a narrow pipeline. Investors watch early data, safety, and platform differentiation.
生物医药行业定位
NKGen occupies a specialized NK-cell niche within biotech. It is catalyst-sensitive because the market still wants proof that the platform can matter clinically.
未来催化剂
- NKGen’s catalysts are NK-cell therapy programs and any update that shows the platform can still advance clinically. The company remains early and highly data-dependent.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。